Comparable outcomes of patients eligible vs ineligible for SWOG leukemia studies

Patients may be deemed ineligible for a clinical trial for reasons that do not directly impact efficacy or safety. We identified reasons for ineligibility and compared outcomes of ineligible with eligible patients treated on Southwest Oncology Group (SWOG) Leukemia Committee protocols. Patients enro...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Blood
Main Authors: Statler, Abby, Othus, Megan, Erba, Harry P., Chauncey, Thomas R., Radich, Jerald P., Coutre, Steven, Advani, Anjali, Nand, Sucha, Ravandi, Farhad, Mukherjee, Sudipto, Sekeres, Mikkael A.
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Hematology 2018
Assuntos:
Clinical Trials and Observations
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6014358/
https://ncbi.nlm.nih.gov/pubmed/29618479
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2018-01-826693
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares